Analysis of the efficacy and tolerability of FOLFIRINOX chemotherapy treatment in patients over 65 years of age with diagnosis of advanced adenocarcinoma of the pancreas.

Małgorzata Domagała-HaduchAmanda RobekJakub WnukŁukasz MichaleckiIwona Gisterek

Published in: Contemporary oncology (Poznan, Poland) (2023)

Triple-drug chemotherapy in a group of patients aged over 65 years with a diagnosis of advanced pancreatic cancer shows similar effectiveness to the general treated population, and with proper medical supervision the severity of side effects is at an acceptable level.

Keyphrases

locally advanced
end stage renal disease
newly diagnosed
ejection fraction
squamous cell carcinoma
randomized controlled trial
chronic kidney disease
healthcare
radiation therapy
emergency department
prognostic factors
adverse drug
drug induced
patient reported
study protocol